Breaking News Instant updates and real-time market news.

PTCT

PTC Therapeutics

$13.27

-0.3 (-2.21%)

08:08
10/17/16
10/17
08:08
10/17/16
08:08

PTC Therapeutics denied appeal for Translarna by FDA

PTC Therapeutics announced that at the end of last week, the Office of Drug Evaluation I, or ODE-I, of the FDA, denied the company's first appeal of the refuse to file letter issued by the FDA's Division of Neurological Products, or DNP, on February 22 regarding PTC's New Drug Application, or NDA, for Translarna for the treatment of nonsense mutation Duchenne muscular dystrophy, nmDMD. The company intends to escalate its appeal to the next supervisory level of the FDA. This is an iterative process and the company anticipates that multiple cycles of appeals to progressively higher levels of the FDA may be required.

  • 06

    Nov

PTCT PTC Therapeutics
$13.27

-0.3 (-2.21%)

07/20/16
WEDB
07/20/16
NO CHANGE
Target $12
WEDB
Neutral
Wedbush staying on sidelines on PTC Therapeutics after NICE issues guidance
Noting that NICE has finalized access for England for PTC Therapeutics' Translarna, Wedbush analyst Heather Behanna said she remains on the sidelines on PTC shares, citing the drug's continued regulatory and pricing risks in Europe. While keeping a Neutral rating and $12 price target on PTC shares, Behanna said she believes it is unlikely that the EMA will pull the drug from the market and sees "meaningful upside" in early 2017 if Translarna can demonstrate a statistically significant positive result in cystic fibrosis.
07/26/16
FBCO
07/26/16
DOWNGRADE
Target $6
FBCO
Neutral
PTC Therapeutics downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Alethia Young downgraded PTC Therapeutics to Neutral and lowered its price target to $6 from $12 citing further uncertainty around the Eurozone DMD approval case. Following the company's release, Young believes that the approval timelines in EU at the best case are now longer than his original expectations though the drug does remain on the market and lowered his probability of success in EMA to 75% from $100.
09/20/16
JEFF
09/20/16
NO CHANGE
Target $7
JEFF
Hold
Jefferies thinks eteplirsen approval will have limited impact on PTC
Jefferies analyst Gena Wang believes yesterday's FDA approval of Sarepta Therapeutics' (SRPT) eteplirsen will have a limited impact on PTC Therapeutics (PTCT). While PTC's potential treatment for Duchenne muscular dystrophy ataluren is considered safe, the FDA approval of eteplirsen is mainly based on the marginal increase of dystrophin level and PTC does not have any dystrophin data from Phase 3, Wang tells investors in a research note. Eteplirsen's approval could pressure the FDA to reconsider the review progress of ataluren, but the final outcome would likely remain the same, the analyst contends. She keeps a Hold rating on PTC with a $7 price target. The stock closed yesterday up 21%, or $1.88, to $10.99.
10/03/16
BOFA
10/03/16
NO CHANGE
Target $15
BOFA
Buy
PTC Therapeutics price target raised to $15 from $9 at BofA/Merrill
BofA/Merrill analyst Tazeen Ahmad raised PTC Therapeutics' price target to $15 from $9 following partner Roche's recruitment for a trial it is conducting to investigate a potential treatment for Spinal Muscular Atrophy, or SMA, patients. Given this advancement, the analyst is raising his probability of approval to 30% from 20% in SMA and maintains his Neutral rating.

TODAY'S FREE FLY STORIES

15:10
12/07/16
12/07
15:10
12/07/16
15:10
General news
U.S. consumer credit rose $16.0 B in October »

U.S. consumer credit rose…

COST

Costco

$151.01

-0.76 (-0.50%)

15:04
12/07/16
12/07
15:04
12/07/16
15:04
Options
Costco options imply 4.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCO

Columbus McKinnon

$27.59

1.07 (4.03%)

15:03
12/07/16
12/07
15:03
12/07/16
15:03
Downgrade
Columbus McKinnon rating change  »

Follow-up: Columbus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

OTTR

Otter Tail

$38.90

0.1 (0.26%)

15:01
12/07/16
12/07
15:01
12/07/16
15:01
Initiation
Otter Tail initiated  »

Otter Tail initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:01
12/07/16
12/07
15:01
12/07/16
15:01
General news
Consumer Credit data reported »

October Consumer Credit…

WDC

Western Digital

$63.85

1.76 (2.83%)

15:00
12/07/16
12/07
15:00
12/07/16
15:00
Options
Western Digital calls active as shares surge »

Western Digital calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCO

Columbus McKinnon

$27.59

1.07 (4.03%)

14:59
12/07/16
12/07
14:59
12/07/16
14:59
Downgrade
Columbus McKinnon rating change  »

Columbus McKinnon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

HON

Honeywell

$116.25

3.18 (2.81%)

14:58
12/07/16
12/07
14:58
12/07/16
14:58
Hot Stocks
Trian declines to comment as Honeywell hits high of day »

Nelson Peltz's Trian…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

  • 16

    Dec

  • 10

    Jan

HRB

H&R Block

$23.42

0.73 (3.22%)

14:55
12/07/16
12/07
14:55
12/07/16
14:55
Technical Analysis
H&R Block technical comments ahead of earnings news »

The shares have been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

APO

Apollo Global

$19.99

0.71 (3.68%)

, CS

Credit Suisse

$15.46

0.77 (5.24%)

14:54
12/07/16
12/07
14:54
12/07/16
14:54
Periodicals
Apollo-backed Warrior working with lenders on IPO for next year, Bloomberg says »

Apollo Global…

APO

Apollo Global

$19.99

0.71 (3.68%)

CS

Credit Suisse

$15.46

0.77 (5.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 14

    Dec

14:50
12/07/16
12/07
14:50
12/07/16
14:50
General news
Canada Capacity Utilization Preview »

Canada Capacity…

LULU

lululemon

$57.24

0.12 (0.21%)

14:49
12/07/16
12/07
14:49
12/07/16
14:49
Options
lululemon options imply 14.0% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Jan

14:45
12/07/16
12/07
14:45
12/07/16
14:45
General news
Canada Housing Starts Preview »

Canada Housing Starts…

14:45
12/07/16
12/07
14:45
12/07/16
14:45
General news
Consumer Credit to be reported at 15:00 »

October Consumer Credit…

14:45
12/07/16
12/07
14:45
12/07/16
14:45
General news
Breaking General news story  »

November Treasury STRIPS…

ATSG

Air Transport Services

$16.32

0.02 (0.12%)

14:42
12/07/16
12/07
14:42
12/07/16
14:42
Hot Stocks
Air Transport Services says preliminary injunction granted in labor matter »

Air Transport Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$190.01

-0.935 (-0.49%)

14:42
12/07/16
12/07
14:42
12/07/16
14:42
Hot Stocks
Allergan CEO: Drug industry should self-regulate pricing »

Allergan CEO Brent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

COST

Costco

$151.01

-0.76 (-0.50%)

, HRB

H&R Block

$23.44

0.75 (3.31%)

14:40
12/07/16
12/07
14:40
12/07/16
14:40
Earnings
Notable companies reporting after market close »

Notable companies…

COST

Costco

$151.01

-0.76 (-0.50%)

HRB

H&R Block

$23.44

0.75 (3.31%)

LULU

lululemon

$57.24

0.12 (0.21%)

CAS

A. M. Castle

UNFI

United Natural Foods

$48.66

-0.7 (-1.42%)

VRNT

Verint

$38.20

0.15 (0.39%)

OLLI

Ollie's Bargain Outlet

$31.50

0.05 (0.16%)

TLRD

Tailored Brands

$18.89

0.58 (3.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 08

    Dec

  • 13

    Dec

  • 15

    Dec

  • 09

    Jan

  • 09

    Jan

HLT

Hilton

$26.81

0.495 (1.88%)

14:40
12/07/16
12/07
14:40
12/07/16
14:40
Options
Heightened call activity in Hilton everyday so far in December »

Heightened call activity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 09

    Dec

TST

TheStreet

14:36
12/07/16
12/07
14:36
12/07/16
14:36
Initiation
TheStreet initiated  »

TheStreet initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

SYK

Stryker

$112.97

0.38 (0.34%)

14:34
12/07/16
12/07
14:34
12/07/16
14:34
Hot Stocks
Stryker raises quarterly dividend to 42.5c per share »

Stryker announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

VNCE

Vince Holding

$4.28

0.075 (1.79%)

14:30
12/07/16
12/07
14:30
12/07/16
14:30
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 09

    Jan

CMA

Comerica

$67.49

-0.2 (-0.30%)

14:30
12/07/16
12/07
14:30
12/07/16
14:30
Periodicals
Comerica moves higher as company alleged to 'warm' to possible sale »

According to Benzinga, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

CX

CEMEX

$8.42

0.205 (2.50%)

14:25
12/07/16
12/07
14:25
12/07/16
14:25
Options
Cemex call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:25
12/07/16
12/07
14:25
12/07/16
14:25
Conference/Events
Senate Commerce, Science & Transportation Committee to hold a hearing »

The Subcommittee on…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.